##gff-version 3
##sequence-region Q02447 1 781
Q02447	UniProtKB	Chain	1	781	.	.	.	ID=PRO_0000047141;Note=Transcription factor Sp3	
Q02447	UniProtKB	Zinc finger	621	645	.	.	.	Note=C2H2-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q02447	UniProtKB	Zinc finger	651	675	.	.	.	Note=C2H2-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q02447	UniProtKB	Zinc finger	681	703	.	.	.	Note=C2H2-type 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q02447	UniProtKB	Region	138	237	.	.	.	Note=Transactivation domain (Gln-rich)	
Q02447	UniProtKB	Region	350	499	.	.	.	Note=Transactivation domain (Gln-rich)	
Q02447	UniProtKB	Region	534	620	.	.	.	Note=Repressor domain	
Q02447	UniProtKB	Compositional bias	21	31	.	.	.	Note=Poly-Gly	
Q02447	UniProtKB	Compositional bias	35	39	.	.	.	Note=Poly-Gln	
Q02447	UniProtKB	Compositional bias	44	100	.	.	.	Note=Ala-rich	
Q02447	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163,PMID:24275569	
Q02447	UniProtKB	Modified residue	551	551	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11812829,ECO:0000269|PubMed:15554904;Dbxref=PMID:11812829,PMID:15554904	
Q02447	UniProtKB	Modified residue	563	563	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q02447	UniProtKB	Modified residue	566	566	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O70494	
Q02447	UniProtKB	Modified residue	646	646	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q02447	UniProtKB	Cross-link	120	120	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12419227;Dbxref=PMID:12419227	
Q02447	UniProtKB	Cross-link	551	551	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
Q02447	UniProtKB	Cross-link	551	551	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
Q02447	UniProtKB	Cross-link	551	551	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q02447	UniProtKB	Cross-link	593	593	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q02447	UniProtKB	Alternative sequence	1	302	.	.	.	ID=VSP_026698;Note=In isoform 4. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Alternative sequence	1	285	.	.	.	ID=VSP_026699;Note=In isoform 3. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Alternative sequence	1	69	.	.	.	ID=VSP_026700;Note=In isoform 5. MTAPEKPVKQEEMAALDVDSGGGGGGGGGHGEYLQQQQQHGNGAVAAAAAAQDTQPSPLALLAATCSKI->M;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12297010;Dbxref=PMID:12297010	
Q02447	UniProtKB	Alternative sequence	1	12	.	.	.	ID=VSP_026701;Note=In isoform 2 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15474306,ECO:0000303|PubMed:15489334;Dbxref=PMID:15474306,PMID:15489334	
Q02447	UniProtKB	Alternative sequence	53	93	.	.	.	ID=VSP_026702;Note=In isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15474306;Dbxref=PMID:15474306	
Q02447	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_016123;Note=T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12297010,ECO:0000269|PubMed:1454515,ECO:0000269|PubMed:15474306;Dbxref=dbSNP:rs1047640,PMID:12297010,PMID:1454515,PMID:15474306	
Q02447	UniProtKB	Mutagenesis	120	120	.	.	.	Note=Some loss of sumoylation. Slight increase in transcriptional activity. Large increase in transcriptional activity%3B when associated with R-551. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12419227;Dbxref=PMID:12419227	
Q02447	UniProtKB	Mutagenesis	551	553	.	.	.	Note=Increases transcriptional activity. KEE->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15494207;Dbxref=PMID:15494207	
Q02447	UniProtKB	Mutagenesis	551	553	.	.	.	Note=200-fold increase in transcriptional activation. KEE->REA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15494207;Dbxref=PMID:15494207	
Q02447	UniProtKB	Mutagenesis	551	553	.	.	.	Note=200-fold increase in transcriptional activation. KEE->RED;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15494207;Dbxref=PMID:15494207	
Q02447	UniProtKB	Mutagenesis	551	552	.	.	.	Note=200-fold increase in transcriptional activation. KE->RA	
Q02447	UniProtKB	Mutagenesis	551	552	.	.	.	Note=200-fold increase in transcriptional activation. KE->RD	
Q02447	UniProtKB	Mutagenesis	551	551	.	.	.	Note=A decreased interaction with HDAC1 and deacetylation of SP3. Increase of about 4.5%25 of activity of the TERT promoter. Decreased recruitment of HDAC1 and increased binding of RNA polymerase II with promoter DNA. K->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12419227,ECO:0000269|PubMed:16781829,ECO:0000269|PubMed:17548428;Dbxref=PMID:12419227,PMID:16781829,PMID:17548428	
Q02447	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Great loss of sumoylation%2C 20-fold increase in transcriptional activity and diffuse nuclear localization. Further small increase in transcriptional activity%3B when associated with R-120. Increased interaction with HDAC1 and deacetylation of SP3. About 50%25 decrease in activity of the TERT promoter. Enhances recruitment of HDAC1 and inhibits binding of RNA polymerase II with promoter DNA. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12419227,ECO:0000269|PubMed:16781829,ECO:0000269|PubMed:17548428;Dbxref=PMID:12419227,PMID:16781829,PMID:17548428	
Q02447	UniProtKB	Sequence conflict	69	69	.	.	.	Note=I->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Sequence conflict	71	71	.	.	.	Note=P->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Sequence conflict	739	739	.	.	.	Note=N->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Sequence conflict	739	739	.	.	.	Note=N->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Sequence conflict	739	739	.	.	.	Note=N->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02447	UniProtKB	Sequence conflict	739	739	.	.	.	Note=N->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
